Skip to main content
Clinical Trials/CTRI/2022/04/042201
CTRI/2022/04/042201
Recruiting
未知

A study of association of Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) and dynapenia/sarcopenia with cardio-metabolic risks

ICMR0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ICMR
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
ICMR

Eligibility Criteria

Inclusion Criteria

  • Adults of age 18\-60 years, with fatty liver disease
  • Obese/Overweight individuals
  • Type 2 Diabetes Mellitus
  • Metabolically dysregulated Lean body individuals
  • Hand grip strength Men \<28 kg, Women \<18 kg
  • Appendicular skeletal muscle mass/height2
  • : Men \<7\.0kg/m2, Women \<5\.4 kg/m2\.
  • SPPB\=8 (The maximum score on the SPPB is:12\)
  • 4\-minute gait speed \<0\.8m/s.

Exclusion Criteria

  • Pregnant women
  • Patient denying consent
  • Cirrhotic liver disease patients
  • Pediatric population

Outcomes

Primary Outcomes

Not specified

Similar Trials